Ubs Group Ag Verastem, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.39 - $0.71 $2,448 - $4,458
-6,279 Reduced 13.06%
41,806 $17,000
Q4 2022

Feb 08, 2023
SELL
$0.33 - $10.44 $2,072 - $65,552
-6,279 Reduced 11.55%
48,085 $19,000
Q3 2022

Nov 10, 2022
SELL
$0.92 - $11.16 $6,257 - $75,910
-6,802 Reduced 11.12%
54,364 $46,000
Q2 2022

Aug 10, 2022
SELL
$1.02 - $1.83 $8,782 - $15,756
-8,610 Reduced 12.34%
61,166 $71,000
Q1 2022

May 16, 2022
SELL
$1.06 - $2.1 $506,842 - $1 Million
-478,153 Reduced 87.27%
69,776 $98,000
Q4 2021

Feb 14, 2022
BUY
$2.05 - $3.2 $90,224 - $140,838
44,012 Added 8.73%
547,929 $1.12 Million
Q3 2021

Nov 15, 2021
BUY
$2.54 - $4.07 $1.04 Million - $1.67 Million
409,726 Added 434.99%
503,917 $1.55 Million
Q2 2021

Aug 13, 2021
SELL
$2.57 - $4.85 $25,286 - $47,719
-9,839 Reduced 9.46%
94,191 $383,000
Q1 2021

May 12, 2021
BUY
$1.9 - $2.82 $2,593 - $3,849
1,365 Added 1.33%
104,030 $257,000
Q4 2020

Feb 11, 2021
BUY
$1.15 - $2.4 $11,458 - $23,913
9,964 Added 10.75%
102,665 $219,000
Q3 2020

Nov 12, 2020
SELL
$1.11 - $1.68 $77,242 - $116,907
-69,588 Reduced 42.88%
92,701 $112,000
Q2 2020

Jul 31, 2020
BUY
$1.69 - $4.2 $108,732 - $270,223
64,339 Added 65.69%
162,289 $279,000
Q1 2020

May 01, 2020
SELL
$1.26 - $3.38 $33,400 - $89,597
-26,508 Reduced 21.3%
97,950 $259,000
Q4 2019

Feb 14, 2020
SELL
$0.86 - $1.44 $6,340 - $10,617
-7,373 Reduced 5.59%
124,458 $167,000
Q3 2019

Nov 14, 2019
SELL
$1.21 - $1.59 $18,058 - $23,729
-14,924 Reduced 10.17%
131,831 $160,000
Q2 2019

Aug 14, 2019
SELL
$1.25 - $3.14 $32,303 - $81,147
-25,843 Reduced 14.97%
146,755 $221,000
Q1 2019

May 14, 2019
SELL
$2.79 - $4.09 $2.93 Million - $4.29 Million
-1,048,896 Reduced 85.87%
172,598 $510,000
Q4 2018

Feb 14, 2019
BUY
$3.23 - $7.01 $3.15 Million - $6.83 Million
974,508 Added 394.56%
1,221,494 $4.1 Million
Q3 2018

Nov 14, 2018
BUY
$6.86 - $9.97 $537,295 - $780,880
78,323 Added 46.44%
246,986 $1.79 Million
Q2 2018

Aug 14, 2018
BUY
$2.88 - $8.67 $30,646 - $92,257
10,641 Added 6.73%
168,663 $1.16 Million
Q1 2018

May 15, 2018
SELL
$2.92 - $3.81 $64,263 - $83,850
-22,008 Reduced 12.22%
158,022 $471,000
Q4 2017

Feb 14, 2018
SELL
$2.99 - $4.85 $193,913 - $314,541
-64,854 Reduced 26.48%
180,030 $553,000
Q3 2017

Nov 14, 2017
BUY
$3.01 - $5.41 $196,483 - $353,148
65,277 Added 36.34%
244,884 $1.15 Million
Q2 2017

Aug 14, 2017
BUY
N/A
61,836 Added 52.51%
179,607 $392,000
Q1 2017

Nov 14, 2017
BUY
N/A
117,771
117,771 $244,000

Others Institutions Holding VSTM

# of Institutions
5
Shares Held
297K
Call Options Held
0
Put Options Held
0
View Full List

About Verastem, Inc.

VSTM Quotes by TradingView
  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.09B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email